Table 3.
Viral-related changes in treatment by 6 months in patients with HBV, HCV, or HIV infectiona
| Chronic HBV (n = 15) | Past HBV (n = 158) | HCV (n = 49) | HIV (n = 30) | |
|---|---|---|---|---|
| Change in treatment due to viral infection | ||||
| Yes | 2 (14) | 12 (8) | 3 (7) | 5 (21) |
| No | 12 (86) | 134 (92) | 42 (93) | 19 (79) |
| Unknown/missing | 1 | 12 | 4 | 6 |
| Type of changeb | ||||
| Reduction of chemotherapy dose | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Omission of anticancer treatment due to viral infection | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Addition of antiviral/antiretroviral therapy | 2 (14) | 8 (5) | 1 (2) | 4 (17) |
| Other change | 0 (0) | 6 (4) | 2 (4) | 1 (4) |
| Change in treatment due to end organ effects of viral infection | ||||
| Yes | 1 (7) | 4 (3) | 2 (5) | 1 (4) |
| No | 13 (93) | 141 (97) | 40 (95) | 25 (96) |
| Unknown/missing | 1 | 13 | 7 | 4 |
| Type of change | ||||
| Reduction of chemotherapy dose | 0 (0) | 1 (1) | 1 (2) | 0 (0) |
| Omission of anticancer treatment due to viral infection | 0 (0) | 0 (0) | 1 (2) | 0 (0) |
| Addition of antiviral/antiretroviral therapy | 1 (7) | 2 (1) | 0 (0) | 1 (4) |
| Other change | 0 (0) | 1 (1) | 0 (0) | 0 (0) |
Abbreviations: HBV, hepatitis B virus; HCV, hepatitis C virus
aValues in table are number of patients (percentage)
bPatients may have had more than 1 change in treatment